TAK

Takeda Pharmaceutical Company Limited

D

TAK

USD

0.07

(0.5074%)

Market Closed

25,822.00

Volume

135.6725

EPS

4.2

Div Yield

45.109

P/E

43,950,078,119.70

Market Cap

Today

0.5074%

1 Week

-0.609%

1 Month

-3.245%

6 Months

4.366%

12 Months

0.544%

Year To Date

-2.804%

All Time

0%

Related Instruments

Title:
Takeda Pharmaceutical Company Limited

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Do you need help or have a question?